---
category: news
title: "Tempus Announces Companion Diagnostic Collaboration With A2 Biotherapeutics"
excerpt: "Tempus, a leader in artificial intelligence and precision medicine, today announced a strategic collaboration to develop a companion diagnostic (CDx) test with A2 Biotherapeutics for its new therapy targeting patients with Loss of Heterozygosity (LOH)."
publishedDateTime: 2021-01-13T19:20:00Z
originalUrl: "https://apnews.com/press-release/business-wire/technology-medical-technology-tumors-diagnosis-and-treatment-health-bbd2bb37dd7b452b9f4f809dc702faf9"
webUrl: "https://apnews.com/press-release/business-wire/technology-medical-technology-tumors-diagnosis-and-treatment-health-bbd2bb37dd7b452b9f4f809dc702faf9"
type: article
quality: 22
heat: 22
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

related:
  - title: "HiberCell and Biodesix Initiate Broad Collaboration for Companion Diagnostic Discovery, Development and Commercialization"
    excerpt: "Biodesix leverages multiple technologies with its proprietary artificial intelligence platform to discover, develop and commercialize diagnostic solutions for unmet clinical needs"
    publishedDateTime: 2021-01-14T06:43:00Z
    webUrl: "https://apnews.com/press-release/business-wire/technology-business-corporate-news-biotechnology-drug-trials-e1214f6c93aa4ac28fabaf54b6dd37be"
    type: article
    provider:
      name: Associated Press
      domain: apnews.com
    quality: 0

secured: "pxISkzc6PjWakvJTgjN3s3A3sDTpBTPkDp9p/LiScLi6TqqTDNpVXh7zAmZe0rOkXETy63zwNdAHLobH1cSQ1hD8cT4RTeqQwoV6SAgDhHFh4FNhStJwfDxBOAX4pOGyqiKuFIFnrlKhNbcFK/9XsJeWaLxJr7si3FqgXE6KlwE14GhqTDGVWdbPhdbVio479YRxWzIeI+UhTQ+DaZzMvMq/AEjjH7rLNbpAFp9OD9m2qTqrMp4WrlFSu1NdF+rAFh3LH4WTKz6m5duqhMP5xOu3EmqnmFgz0CFWbTTcE+LhVSg7scRE6dsB+lAYSvqtHqc6Mefntc1XA6Hw/pxDSmr6+4ankrifsFauFlDqTrM=;5x/9Y34J+E3yCe5VW0RfAg=="
---

